Literature DB >> 12225394

Multiple gammac-receptor expression in adult T-cell leukemia.

Hirofumi Baba1, Yasuaki Yamada, Naoki Mori, Toshihisa Hayashibara, Hitomi Harasawa, Kazuto Tsuruda, Kazuyuki Sugahara, Hiroshi Soda, Yumi Takasaki, Masayuki Tawara, Yoichi Hirakata, Masao Tomonaga, Shimeru Kamihira.   

Abstract

Constitutive expression of the IL-2 receptor (IL-2R) on adult T-cell leukemia (ATL) cells and the presence of permanent IL-2-dependent ATL cell lines indicate that the signal transduction system via IL-2R is a key element for the development of this disease. IL-2R is a member of the common gamma-chain (gammac)-receptor family and shares gamma with IL-4R, IL-7R, IL-9R, and IL-15R. In addition to IL-2R, ATL cells express IL-15R and respond to IL-15. In the present study, we examined other members of this receptor family. ATL cells showed various levels of IL-4Ralpha (CD124) and IL-7Ralpha (CD127) expression, and responded to these cytokines. In contrast, ATL cells hardly responded to IL-9. As primary samples were a mixed population and the results may have been modified by contaminating normal cells, we used ATL cell lines as pure ATL cell populations. Here, we report that IL-2-dependent ATL cell lines also express IL-4Ralpha and respond to IL-4, which was verified by the activation of cytoplasmic transcriptional activator Stat6 protein. Moreover, a novel ATL cell line that grows stably in an IL-7-dependent manner was established from one of the cell lines, and IL-7 induced Stat5 activation in this cell line. These results indicated that ATL cells have the potential to express all gammac-receptors except IL-9R. Overlapping and switching of cytokine receptors supported the idea that ATL cells can rapidly select the appropriate gammac-receptor according to conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225394     DOI: 10.1034/j.1600-0609.2002.00653.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.

Authors:  T Kameda; K Shide; H K Shimoda; T Hidaka; Y Kubuki; K Katayose; Y Taniguchi; M Sekine; A Kamiunntenn; K Maeda; K Nagata; T Matsunaga; K Shimoda
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

2.  Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Authors:  Jing Chen; Mike Petrus; Bonita R Bryant; Vinh Phuc Nguyen; Mindy Stamer; Carolyn K Goldman; Richard Bamford; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

3.  Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.

Authors:  Tekla Hornakova; Judith Staerk; Yohan Royer; Elisabetta Flex; Marco Tartaglia; Stefan N Constantinescu; Laurent Knoops; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

4.  Targeting the IL-9 pathway in cancer immunotherapy.

Authors:  Ningbo Zheng; Yong Lu
Journal:  Hum Vaccin Immunother       Date:  2020-02-10       Impact factor: 3.452

Review 5.  Cell surface markers in HTLV-1 pathogenesis.

Authors:  Andrea K Kress; Ralph Grassmann; Bernhard Fleckenstein
Journal:  Viruses       Date:  2011-08-16       Impact factor: 5.048

6.  Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.

Authors:  Huseini H Kagdi; Maria A Demontis; Paul A Fields; Juan Carlos Ramos; Charles R M Bangham; Graham P Taylor
Journal:  Cancer Med       Date:  2016-12-30       Impact factor: 4.452

Review 7.  Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.

Authors:  Inbal Azran; Yana Schavinsky-Khrapunsky; Mordechai Aboud
Journal:  Retrovirology       Date:  2004-08-13       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.